Describe Cierny–Mader Classification in detail.

Purpose

The Cierny–Mader classification stages chronic (adult) osteomyelitis to guide treatment and prognosis. It combines the anatomical extent of bone involvement with the physiological status (host) of the patient, recognising that both determine the outcome of surgery.

Host (physiological) Class

The patient is graded as A (normal host, good immunity and healing), B (compromised — systemic Bs, e.g. Diabetes, malnutrition, immunosuppression; local Bl, e.g. Scarred/irradiated tissue, arteriopathy; or both), or C (treatment is more morbid than the disease, so palliation/suppression is chosen). The combination (type + class) gives the clinical stage.

Clinical Use

The stage guides the aggressiveness of treatment: medullary and localised disease in a good host may be cured by debridement and antibiotics, whereas diffuse disease in a compromised host requires major reconstruction and carries a higher failure rate — and a class-C host may be best served by suppressive therapy rather than radical surgery.

Contrast with Paediatric Classification

Cierny–Mader applies to adult osteomyelitis and deliberately incorporates the host, reflecting that comorbidity and tissue quality drive outcome in adults. This contrasts with the simpler descriptive approach to acute haematogenous osteomyelitis in children, where the host is usually healthy and treatment centres on early antibiotics and drainage. The staging is most useful when planning reconstructive surgery and counselling on the likelihood of cure.

Combines bone involvement with host status to guide treatment.

• Stages chronic osteomyelitis by anatomy (I medullary – IV diffuse) + host (A/B/C).
• Host class reflects immunity, comorbidity and local tissue quality.
• Guides whether to attempt cure vs suppression, and the scale of surgery.
• Optimising the host is as important as addressing the anatomy.